BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma

BACKGROUND: Clinical variables may correlate with lack of response to treatment (primary resistance) or clinical benefit in patients with clear cell renal cell carcinoma (ccRCC) treated with anti-programmed death 1/ligand one antibodies. METHODS: In this multi-institutional collaboration, clinical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Labadie, Brian W., Liu, Ping, Bao, Riyue, Crist, Michael, Fernandes, Ricardo, Ferreira, Laura, Graupner, Scott, Poklepovic, Andrew S., Duran, Ignacio, Maleki Vareki, Saman, Balar, Arjun V., Luke, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878694/
https://www.ncbi.nlm.nih.gov/pubmed/31767020
http://dx.doi.org/10.1186/s12967-019-02144-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878694/
https://www.ncbi.nlm.nih.gov/pubmed/31767020
http://dx.doi.org/10.1186/s12967-019-02144-7

Ejemplares similares